Aug 30 (Reuters) - BCAL Diagnostics (BDX) :
- FY NET LOSS ATTRIBUTABLE A$5.1 MILLION VERSUS LOSS OF A$3.4 MILLION
- FY REVENUE FROM ORDINARY ACTIVITIES A$2.9 MILLION VERSUS A$718,669
News: BDX Bcal Diagnostics Posts FY Net Loss Attributable A$5.1 Million
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.25M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22058 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 5714 | 1 |
View Market Depth
| Last trade - 16.21pm 23/07/2025 (20 minute delay) ? |
| BDX (ASX) Chart |
Day chart unavailable